Erin E. Stebbins

533 total citations
11 papers, 211 citations indexed

About

Erin E. Stebbins is a scholar working on Parasitology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Erin E. Stebbins has authored 11 papers receiving a total of 211 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Parasitology, 4 papers in Epidemiology and 2 papers in Infectious Diseases. Recurrent topics in Erin E. Stebbins's work include Parasitic Infections and Diagnostics (10 papers), Pneumocystis jirovecii pneumonia detection and treatment (4 papers) and Coccidia and coccidiosis research (2 papers). Erin E. Stebbins is often cited by papers focused on Parasitic Infections and Diagnostics (10 papers), Pneumocystis jirovecii pneumonia detection and treatment (4 papers) and Coccidia and coccidiosis research (2 papers). Erin E. Stebbins collaborates with scholars based in United States, Germany and United Kingdom. Erin E. Stebbins's co-authors include Christopher D. Huston, Peter G. Miller, Rajiv S. Jumani, Melissa S. Love, Case W. McNamara, Marvin J. Meyers, Kovi Bessoff, Mary Ann Campbell, David W. Griggs and John Barlow and has published in prestigious journals such as Nature Communications, Journal of Medicinal Chemistry and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Erin E. Stebbins

11 papers receiving 211 citations

Peers

Countries citing papers authored by Erin E. Stebbins

Since Specialization

Citations

This map shows the geographic impact of Erin E. Stebbins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erin E. Stebbins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erin E. Stebbins more than expected).

Fields of papers citing papers by Erin E. Stebbins

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erin E. Stebbins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erin E. Stebbins. The network helps show where Erin E. Stebbins may publish in the future.

Co-authorship network of co-authors of Erin E. Stebbins

This figure shows the co-authorship network connecting the top 25 collaborators of Erin E. Stebbins. A scholar is included among the top collaborators of Erin E. Stebbins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erin E. Stebbins. Erin E. Stebbins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

#	Work	Indexed citations
1	Cryptosporidium life cycle small molecule probing implicates translational repression and an Apetala 2 transcription factor in macrogamont differentiation 2024 ·PLoS Pathogens ·(unknown), (unknown), (unknown), Rajiv S. Jumani, Erin E. Stebbins, (unknown), (unknown), Melissa S. Love, Case W. McNamara, Christopher D. Huston	2
2	Identification of potent and orally efficacious phosphodiesterase inhibitors in Cryptosporidium parvum-infected immunocompromised male mice 2024 ·Nature Communications ·(unknown), (unknown), (unknown), (unknown), (unknown), Peter G. Miller, (unknown), Erin E. Stebbins, Scott Campbell, David W. Griggs, Thomas Spangenberg, Marvin J. Meyers, Christopher D. Huston	5
3	Structure–Activity Relationship Studies of the Aryl Acetamide Triazolopyridazines against Cryptosporidium Reveals Remarkable Role of Fluorine 2023 ·Journal of Medicinal Chemistry ·(unknown), (unknown), H. W. Peek, (unknown), (unknown), Erin E. Stebbins, Peter G. Miller, (unknown), Francis M. Sverdrup, David W. Griggs, Christopher D. Huston, Marvin J. Meyers	6
4	Spontaneous Selection of Cryptosporidium Drug Resistance in a Calf Model of Infection 2021 ·Antimicrobial Agents and Chemotherapy ·(unknown), Erin E. Stebbins, Robert K. M. Choy, J. Robert Gillespie, Eugenio L. de Hostos, Peter G. Miller, (unknown), Ranae M. Ranade, (unknown), Christophe L. M. J. Verlinde, Adam Sateriale, Zhongsheng Zhang, Damon M. Osbourn, David W. Griggs, Erkang Fan, Frederick S. Buckner, Christopher D. Huston	16
5	Optimization of the Urea Linker of Triazolopyridazine MMV665917 Results in a New Anticryptosporidial Lead with Improved Potency and Predicted hERG Safety Margin 2021 ·Journal of Medicinal Chemistry ·(unknown), (unknown), (unknown), Erin E. Stebbins, Peter G. Miller, (unknown), (unknown), Scott Campbell, David W. Griggs, Christopher D. Huston, Marvin J. Meyers	13
6	Identification of anisomycin, prodigiosin and obatoclax as compounds with broad-spectrum anti-parasitic activity 2020 ·PLoS neglected tropical diseases ·Gretchen Ehrenkaufer, Pengyang Li, Erin E. Stebbins, (unknown), Anjan Debnath, (unknown), (unknown), Joseph L. DeRisi, (unknown), Ellen Yeh, (unknown), Ludovica Monti, Conor R. Caffrey, Christopher D. Huston, Bo Wang, Upinder Singh	21
7	A suite of phenotypic assays to ensure pipeline diversity when prioritizing drug-like Cryptosporidium growth inhibitors 2019 ·Nature Communications ·Rajiv S. Jumani, (unknown), Erin E. Stebbins, (unknown), Peter G. Miller, (unknown), Kovi Bessoff, (unknown), Melissa S. Love, Case W. McNamara, Christopher D. Huston	29
8	Identification of a potent benzoxaborole drug candidate for treating cryptosporidiosis 2019 ·Nature Communications ·Christopher S. Lunde, Erin E. Stebbins, Rajiv S. Jumani, Mahmudul Hasan, Peter G. Miller, John Barlow, Yvonne R. Freund, Pamela Berry, Rianna Stefanakis, Jiří Gut, Philip J. Rosenthal, Melissa S. Love, Case W. McNamara, Eric E. Easom, Jacob J. Plattner, Robert T. Jacobs, Christopher D. Huston	44
9	A Novel Piperazine-Based Drug Lead for Cryptosporidiosis from the Medicines for Malaria Venture Open-Access Malaria Box 2018 ·Antimicrobial Agents and Chemotherapy ·Rajiv S. Jumani, Kovi Bessoff, Melissa S. Love, Peter G. Miller, Erin E. Stebbins, (unknown), Mary Ann Campbell, Marvin J. Meyers, Jennifer A. Zambriski, (unknown), Ashley K. Woods, Case W. McNamara, Christopher D. Huston	44
10	Clinical and microbiologic efficacy of the piperazine-based drug lead MMV665917 in the dairy calf cryptosporidiosis model 2018 ·PLoS neglected tropical diseases ·Erin E. Stebbins, Rajiv S. Jumani, (unknown), John Barlow, Peter G. Miller, Mary Ann Campbell, Marvin J. Meyers, David W. Griggs, Christopher D. Huston	22
11	Amixicile Reduces Severity of Cryptosporidiosis but Does Not Have In Vitro Activity against Cryptosporidium 2018 ·Antimicrobial Agents and Chemotherapy ·Luther A. Bartelt, (unknown), Glynis L. Kolling, Erin E. Stebbins, Christopher D. Huston, Richard L. Guerrant, Paul S. Hoffman	9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact